AOneFittness | AOneFittness

Fitt Factor Seven Weight Loss Clinical Study

Jan 16th 2011 at 9:08 PM

The effects of a 6 week weight management program, utilizing non-pharmaceutical nutritional supplements, on weight reduction, subjective energy level, cholesterol, triglycerides, adipose tissue and liver enzymes in obese adults

Dr. Gerald W. Lane, Administrative Director of Metabolic Reasearch

Institute for Metabolic Research, Columbus, Ohio

Dr. Lane is Administrative Director of Research at The Institute for Metabolic Research, Columbus Ohio. He is a graduate of Ohio University College of Osteopathic Medicine, Athens, Ohio. Past Medical Director of Hilltop Research and Radiant Research, Columbus Ohio. Contributor toward greater than 250 clinical research projects over 15 years. Past Clinical Associate Professor of Medicine, Ohio University, College of Osteopathic Medicine, Athens, Ohio

Direct correspondence to: Dr. Gerald Lane

email: ifmresearch@aol.com

Key words: weight management, obesity, nutritional supplements, liver enzymes

Abstract

Introduction

Obesity is the number one contributor to the development of heart disease, diabetes mellitus and atherosclerosis in developed countries. The toll on human existence, both medically and economically is immense. While we cannot alter genetic factors contributing to obesity, cholesterol and triglycerides and diabetes, we can successfully address the exogenous contribution to these disease states.

Pharmaceutical attempts to promote weight loss have historically been accomplished via appetite suppressants that many times are addictive and or have cardiovascular side effects. The prescribing patterns of these medications are closely monitored by the board of pharmacy in most states, due to abuse and miss-use by patients and prescribers. This study was conducted to document scientifically an effective and safe mechanism to help obese individuals lose weight. The results of this study bear out that there are safe, effective adjuncts to weight loss without the need for prescription medication or frequent physician visits.

RESULTS

A nutritional supplement program studied 35 participants to determine safety and efficacy of the products (a liquid nutrient concentrate) while measuring weight reduction, lipids, adipose tissue and liver enzymes over a 6 week period. This was an open label trial with obese adults which measured total weight, percentage of body fat, andropometric measurements of mid-arm circumference, abdomen, hips, thighs, caliper measurements of skin folds of triceps, supraliac and mid-thigh (female) and caliper measurements of skin folds of chest, abdomen and mid-thigh (males), electrolytes, glucose, cholesterol, triglycerides, albumen, total protein, bilirubin, BUN, Creatinine, SGOT, SGPT, and subjective energy levels (self reported by participants). The group participated in a 72 hour program utilizing only the nutritional supplements and hydration. The results were remarkable. Every subject in the program lost weight with an average weight loss of 8.7 pounds. They then continued to utilize the nutritional products to replace one meal per day for 39 additional days. The average weight loss after 14 days was 18.2 pounds and 28.4 pounds at the conclusion of the 6 week trial.

Patient’s metabolic functions were closely monitored in order to document therapeutic benefit, while monitoring for potential side effects. Total cholesterol was lowered in all participants (ave. reduction = 20.6) and every participant with clinically elevated cholesterol (≥ 200) at baseline, reported normal values after 6 weeks. Similarly, all participants with fasting hyperglycemia (s. glu. ≥ 100) returned to normal by the end of the study. This included 3 patients with NIDDM who were not well controlled prior to the study. There was no evidence of hypoglycemia (s. glu. ≤ 65). Participants with elevated liver enzymes at baseline reported normal SGOT & SGPT levels after 2 weeks. No participant developed liver enzyme elevations. Subjective energy level of the participants was reported at baseline as low to average and reported as high to very high at the conclusion of the study. All participants lost total adipose tissue with the average change calculated at 6.7% lost. Decrease in total inches of body fat paralleled that of weight. For each pound of weight lost, the participants lost 0.82” off of body measurements.

2 comments
Please to comment
Jan 17th 2011 at 5:13 PM by AOneFittness
Thank you. The study was the 4th of it's kind, using our weight loss system. We know it worked and we knew it was safe, but now with the clinical evidence to support both claims, we are very proud and confident. No gimmicks. Just results. If your would like to be a distributor or know someone who would like to represent a great weight loss solution, contact me a distributor@aonefittness.com Thank you for your comments. Debbie CEO, A One Fittness, Inc.
   
Jan 17th 2011 at 4:12 PM by 4SFI
Useful article. I like it.
   

sign in

Username
Password
Remember Me


New to IM faceplate? join free!

Lost Password? click here